BioMed X (Heidelberg, Germany) has announced the start of its “Ukraine Refugee Funding Programme” that supports doctoral students and masters-level researchers in the life sciences who cannot continue their work at institutions in Ukraine. In collaboration with some of its partners, BioMed X aims to give these scientists the opportunity to continue their work in a research group at the BioMed X Institute in Heidelberg for a period of up to four years. Candidates should have a master’s degree, as well as research experience, in either molecular/cell biology, bio-organic chemistry, pharmacology, or physics. Knowledge of the German language is not required.
Thomas Rückle, Senior VP and Head of Research at the BioMed X Institute, commented: “The situation in Ukraine is a tragedy that requires a joint effort to offer support and help. Our BioMed X Institute is a place where early-career scientists are given the opportunity to develop themselves. Together with some of our partners we launched this funding programme because we sincerely hope to provide a scientific home for some of the researchers who cannot continue their career in Ukraine.”
For further information, please click here: https://bio.mx/landingpage/ukraine
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.